resisttb
- Jul 14, 2021
- 1 min read

WHO 2021 Genetic Susceptibility Testing Statement

This document summarizes the WHO’s review of various diagnostics for TB. Most of it is not new, but important additions are evaluation of molecular methods for detection of resistance to INH (pages 50 and 87) and PZA (page 115). Read below.

WHO 2021 Genetic Susceptibility testing statement

.pdf

Download PDF • 3.72MB

Recent Posts

See All

The Rejection of the Bedaquiline Patent Opposition in Indonesia Raises the Risk of Difficulty in Accessing Optimal TB Therapy

The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB) drug Bedaquiline with dispersible tablet formulations (hereinafter, i

To Prepare For The Next Pandemic, We Must Spend Now On TB And Other Major Diseases

Calls for strengthening health systems in preparation for the next pandemic have intensified in the wake of COVID-19, with estimates ranging from $15 billion to $50 billion needed annually to scale up

WHO European Region: Data collection guide - indicators for meaningful involvement of civil society in TB response

The monitoring and evaluation framework of the TB Action Plan for the WHO European Region 2023–2030 includes four new indicators reflecting consistent meaningful engagement of the communities and civi